# A Gene Therapy Study for Hemophilia B

> **NCT02484092** · PHASE2 · COMPLETED · sponsor: **Pfizer** · enrollment: 15 (actual)

## Conditions studied

- Hemophilia B

## Interventions

- **BIOLOGICAL:** SPK-9001

## Key facts

- **NCT ID:** NCT02484092
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11-18
- **Primary completion:** 2019-04-08
- **Final completion:** 2019-04-08
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2020-06-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02484092

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02484092, "A Gene Therapy Study for Hemophilia B". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02484092. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*